Annulus Therapeutics
Science Pipeline About Us Advisors News
Contact Us
Science Pipeline About Us Advisors News
Legal

Terms of Use

Effective date: [8/31/26]

1. Acceptance of Terms

These Terms of Use ("Terms") govern your access to and use of annulustx.com (the "Site"), operated by Annulus Therapeutics, Inc. ("Annulus," "we," "us," or "our"). By accessing or using the Site, you agree to be bound by these Terms. If you do not agree, please do not use the Site.

2. Use of This Site

The Site and its contents are provided for general informational purposes about Annulus, its science, and its pipeline. You may view and print pages of the Site for your own personal, non-commercial use, provided you keep all copyright and proprietary notices intact. You may not reproduce, distribute, modify, or create derivative works from the Site's content, or use it for any commercial purpose, without our prior written consent.

3. Intellectual Property

The Site and its content — including text, graphics, logos, and the Annulus name and marks — are owned by Annulus or its licensors and are protected by copyright, trademark, and other intellectual property laws. Nothing on the Site grants you any license or right to use any Annulus trademark or logo without our prior written permission.

4. No Medical, Investment, or Professional Advice

Content on the Site is provided for general informational purposes only and does not constitute medical, clinical, investment, or professional advice, and is not intended to diagnose, treat, cure, or prevent any disease. AN-113 and any other compound described on the Site is an investigational product. It has not been approved by the U.S. Food and Drug Administration or any other regulatory authority, its safety and efficacy have not been established, and it is not available for prescription or use outside of a clinical trial setting.

Nothing on the Site is, or should be construed as, an offer to sell or a solicitation of an offer to buy any security, or investment advice of any kind.

5. Forward-Looking Statements

The Site may contain forward-looking statements regarding our research programs, product candidates, and business plans. These statements are based on current expectations and assumptions and are subject to substantial risks and uncertainties. Actual results may differ materially. We undertake no obligation to update any forward-looking statement, except as required by law.

6. Third-Party Links

The Site may link to third-party websites for your convenience. We do not control and are not responsible for the content, accuracy, or practices of any third-party site, and inclusion of a link does not imply our endorsement.

7. Disclaimer of Warranties

The Site and its content are provided "as is" and "as available," without warranties of any kind, express or implied, including warranties of merchantability, fitness for a particular purpose, non-infringement, or that the Site will be accurate, complete, uninterrupted, or error-free.

8. Limitation of Liability

To the fullest extent permitted by law, Annulus and its officers, directors, employees, and agents will not be liable for any indirect, incidental, special, consequential, or punitive damages, or any loss of data, revenue, or profits, arising from or related to your use of, or inability to use, the Site.

9. Indemnification

You agree to indemnify and hold Annulus harmless from any claims, losses, liabilities, and expenses (including reasonable attorneys' fees) arising out of your use of the Site or your violation of these Terms.

10. Governing Law

These Terms are governed by the laws of the State of Maryland, without regard to its conflict-of-laws principles, and any dispute arising from these Terms or the Site will be subject to the exclusive jurisdiction of the state and federal courts located in Maryland.

11. Changes to These Terms

We may revise these Terms from time to time. Changes are effective when posted to this page, and we will update the effective date above accordingly. Your continued use of the Site after changes are posted constitutes acceptance of the revised Terms.

12. Contact Us

Questions about these Terms can be directed to:
Annulus Therapeutics, Inc.
3030 Greenmount Ave Ste 300 PMB 751126
Baltimore, Maryland 21218-6907 US
info@annulustx.com

Annulus Therapeutics
Company Science Pipeline About Us Advisors News
Connect info@annulustx.com
Legal Privacy Policy Terms of Use

© 2026 Annulus Therapeutics, Inc. All rights reserved.

AN-113 is an investigational compound. It has not been approved by the FDA or any other regulatory authority.